| SC 13G/A | 2023-02-14 | Avidity Partners Management LP | PhaseBio Pharmaceuticals Inc | 2,040,000 | 4.1% | EDGAR |
| SC 13G/A | 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. | PhaseBio Pharmaceuticals Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Rock Springs Capital Management LP | PhaseBio Pharmaceuticals Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | PhaseBio Pharmaceuticals Inc | 0 | 0.0% | EDGAR |
| SC 13D/A | 2022-11-04 | NEW ENTERPRISE ASSOCIATES 13 LP | PhaseBio Pharmaceuticals Inc | - | - | EDGAR |
| SC 13G/A | 2022-07-19 | MAI Capital Management | PhaseBio Pharmaceuticals Inc | 2,675,376 | 5.8% | EDGAR |
| SC 13G/A | 2022-02-15 | Rock Springs Capital Management LP | PhaseBio Pharmaceuticals Inc | 2,581,299 | 5.4% | EDGAR |
| SC 13G/A | 2022-02-14 | Avidity Partners Management LP | PhaseBio Pharmaceuticals Inc | 4,405,000 | 9.2% | EDGAR |
| SC 13G/A | 2022-02-14 | Rosalind Advisors, Inc. | PhaseBio Pharmaceuticals Inc | 707,467 | 1.5% | EDGAR |
| SC 13G/A | 2022-02-14 | RA CAPITAL MANAGEMENT, L.P. | PhaseBio Pharmaceuticals Inc | 2,850,000 | 5.9% | EDGAR |
| SC 13G | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | PhaseBio Pharmaceuticals Inc | 2,869,650 | 6.0% | EDGAR |
| SC 13G/A | 2022-02-01 | JOHNSON & JOHNSON | PhaseBio Pharmaceuticals Inc | 1,607,044 | 3.3% | EDGAR |
| SC 13G/A | 2021-11-10 | WELLINGTON MANAGEMENT GROUP LLP | PhaseBio Pharmaceuticals Inc | 1,925,080 | 4.0% | EDGAR |
| SC 13G/A | 2021-08-10 | WELLINGTON MANAGEMENT GROUP LLP | PhaseBio Pharmaceuticals Inc | 6,014,889 | 12.5% | EDGAR |
| SC 13G | 2021-05-19 | Rosalind Advisors, Inc. | PhaseBio Pharmaceuticals Inc | 2,607,857 | 5.4% | EDGAR |
| SC 13G | 2021-03-24 | RA CAPITAL MANAGEMENT, L.P. | PhaseBio Pharmaceuticals Inc | 2,850,000 | 6.0% | EDGAR |
| SC 13G | 2021-03-22 | Avidity Partners Management LP | PhaseBio Pharmaceuticals Inc | 4,285,000 | 9.4% | EDGAR |
| SC 13G/A | 2021-02-16 | Rock Springs Capital Management LP | PhaseBio Pharmaceuticals Inc | 1,314,374 | 4.5% | EDGAR |
| SC 13G/A | 2021-01-11 | WELLINGTON MANAGEMENT GROUP LLP | PhaseBio Pharmaceuticals Inc | 1,567,656 | 5.3% | EDGAR |
| SC 13G | 2020-11-16 | Rock Springs Capital Management LP | PhaseBio Pharmaceuticals Inc | 1,651,874 | 5.6% | EDGAR |